Placebointerventionen in der medizinischen Praxis

Fässler, M.
December 2010
Praxis (16618157);12/1/2010, Vol. 99 Issue 24, p1495
Academic Journal
No abstract available.


Related Articles

  • The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice. Calvert, Melanie; Brundage, Michael; Jacobsen, Paul B.; Sch√ľnemann, Holger J.; Efficace, Fabio // Health & Quality of Life Outcomes;2013, Vol. 11 Issue 1, p1 

    To inform clinical guidelines and patient care we need high quality evidence on the relative benefits and harms of intervention. Patient reported outcome (PRO) data from clinical trials can "empower patients to make decisions based on their values" and "level the playing field between physician...

  • Not all placebos are the same: a debate on the ethics of placebo use in clinical trials versus clinical practice. Cahana, Alex; Romagnioli, Simone // Journal of Anesthesia;2007, Vol. 21 Issue 1, p102 

    A case study is presented regarding the debate on ethics of placebo use in clinical trials and clinical practice. The use of placebo in the management of pain medicine has been long debated. Placebo use in clinical trials may include determining clinical efficacy of a treatment and control in an...

  • The Use of Placebos in Clinical Trials and Clinical Practice. Kirsch, Irving // Canadian Journal of Psychiatry;Apr2011, Vol. 56 Issue 4, p191 

    The article reflects on the use of placebos in clinical trials and clinical practice. It examines the use of placebos in clinical practice and the dissatisfaction with its use in clinical trials. It argues why clinical trials are necessary in evaluating psychiatric drugs. According to a...

  • Therapeutic strategies for functional dyspepsia and the introduction of the Rome III classification. Suzuki, Hidekazu; Nishizawa, Toshihiro; Hibi, Toshifumi // Journal of Gastroenterology;Jun2006, Vol. 41 Issue 6, p513 

    Although placebo response rates in clinical trials for functional dyspepsia (FD) are more than 30%, a recent meta-analysis based on randomized controlled trials (RCTs) showed that antisecretory drugs were more or less superior to placebos. On the other hand, large-scale RCTs on the efficacy of...

  • Placebos and the UK Medical Research Council--and the consumer perspective. Box, Joan E. // Science & Engineering Ethics;Jan2004, Vol. 10 Issue 1, p95 

    The UK Medical Research Council, in order to further its mission of maintaining and improving human health, supports a substantial number of clinical trials on a wide variety of medical questions; some of these trials involve the use of placebos as controls or to maintain blinding. Before...

  • Use of placebo in clinical trials.  // WHO Drug Information;2001, Vol. 15 Issue 2, p70 

    Discusses the use of placebo in clinical trials, under the revised Declaration of Helsinki. Conditions that govern and restrict the use of placebo in order to avoid unethical use of placebo; Need to respect the patient's right to withdraw at any time, but still receive conventional treatment.

  • Equipoise, a term whose time (if it ever came) has surely gone. Sackett, David L. // CMAJ: Canadian Medical Association Journal;10/03/2000, Vol. 163 Issue 7, p835 

    Offers a rebuttal to the commentary of Drs. Stanley H. Shapiro and Kathleen Cranley Glass in an article that appears in this issue. Disagreement over the use of the term 'equipoise'; Disagreement over the issue of individual uncertainty as it applies to randomized controlled trials; Suggestion...

  • Trials in Latin America. Nievas, Ofelia Rodriguez; Schefler, Sandra Grosworsel // Applied Clinical Trials;Jul2010, Vol. 19 Issue 7, p52 

    The article discusses the conducted clinical trials and the introduction of Good Clinical Practice policy department in Latin America. Clinical trials consider the efficiency of investigational teams, updated regulations and the overall standard of care to become successful scientific and...

  • Recruitment Rates and Data Quality. Platonov, Pyotr G.; Escandon, Rafael; Varshavsky, Sergei // Applied Clinical Trials;Nov2003, Vol. 12 Issue 11, p32 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics